Back in 2014, researchers published the results of a study in the journal PLoS One that showed the complete destruction of tumours, without relapse, in 75% of laboratory mice treated with direct injections of EBC-46 into the cancerous cells. In some cases, this destruction occurred in as little as 48 hours.
Dr. Glen Boyle was the lead author of that study, conducted by a team of cancer scientists at the Queensland Institute of Medical Research, Australia as well as the private pharmaceutical company QBiotics.  The team extracted a compound from seeds contained in the berry of the Blushwood tree (Fontainea picrosperma), which only grows in the Atherton Tablelands, an area of Rainforest in the North of Queensland.
At the time, Boyle stated that “in most cases a single injection starts killing the cancer off in 4-5 hours.” He also said “the compound works in three ways – it kills the tumour, cuts off the blood supply and activates the immune system to clear it all up.”
In extremely broad brushstrokes, researchers posit that the compound achieves these goals primarily by activating an enzyme called Protein Kinase C, though the exact mechanisms remain unclear.
In December 2016 an article entitled “Scientists find Australian berry to cure cancer in 48 hours!” started doing the rounds and is still being widely shared, but is this 100% true??

Before posting something on this blog, I thoroughly research the subject on various trusted cancer and research sites, as well as searching across the web for the most current information available, and regarding this subject, this is what I have found:
QBiotics holds the patent to EBC-46 and trials were first conducted on mice, cats, dogs, and horses through direct injections, first with melanoma models as well as cancers of the head and neck, where the response and cure were long-term and ‘enduring’ with little or no relapse in more than 70% of the pre-clinical cases.
Work then moved on to cancers of the colon, breast and prostate cancers, and the results showed a 75% success rate.
QBiotics moved on to Human trials; 8 different patients with 4 different cancers were treated across Australia. The cancers – melanoma, squamous cell carcinoma, basal cell carcinoma and breast adenocarcinoma, were all successfully treated.
According to  Dr. Victoria Gordon, CEO of QBiotics, none of the patients showed any side-effects:
It’s proving our theory that it’s not species-specific, and it’s not tumour-specific either, because it’s actually working in a range of tumours.
According to QBiotics, animal studies have been successful enough to bring EBC-46 to the trial phase as a medicine for tumors in dogs and horses, with future trials in the works for cats:
In treatment of over 100 dogs, cats and horses, intralesional injection of EBC-46 has successfully ablated or significantly palliated a range of advanced, inoperable tumours (melanomas, sarcomas, carcinomas, mast cell tumours and sarcoids) while causing no significant long-term side effects. A topical formulation of EBC-46 has also been used to successfully treat ulcerative squamous cell carcinomas on cats and horses.
QBiotics has begun a Phase I trial of EBC-46 in humans, as stated on their website:
EBC-46 is currently being evaluated for safety in a Clinical Phase I trial in patients with cutaneous or subcutaneous solid tumours. Such tumours include melanoma, head and neck cancer, SCC and BCC of the skin and Merckel cell carcinoma. In this trial, EBC-46 is delivered locally in a single treatment by direct injection into tumours. The trial is being conducted in Australia by clinicians in Sydney, Melbourne, Brisbane and Adelaide.
Australia’s National Health and Medical Research Council describes a Phase I clinical trial as follows:

Phase I clinical trials are done to test a new biomedical intervention for the first time in a small group of people (e.g. 20-80) to evaluate safety (e.g. to determine a safe dosage range and identify side effects).

 
More can be read on the human trials in this study, “Phase 1 dose-escalation study of EBC-46 given by intratumoral injection to patients with refractory cutaneous and subcutaneous tumors.”
or HERE
So, in conclusion, while EBC-46 has shown a lot of promise, we still have a long way to go before it is approved or disapproved for human use, so don’t go out picking blushwood berries just yet… and be wary of sites that are advertising the “Blushwood Berry Extract Miracle Cure”
 
 

0 thoughts to “What Happened to the EBC-46 Miracle Cancer Drug?

  • Markus Berthold

    Amazing enough and I am sure thanks to the powers that be , while the drug has been proved to work 100% in humans with all types pretty much of cancer !!! They just got done approving it for use for cancer in dogs in the USA starting October 2018 by the FDA , so the moral of the story is F people and lets keep using the good expensive Chemo and Radiation on humans !!! explains and tells you a lot right there even after human trials phase II having been completed with success after all this started in 2014 , just unbelievable , its not even a drug is fraking NATURAL with no side effects , you’re kidding me ? people have to revolt and stand up to this ABSURD !!! meanwhile kids adults and families with no hope can just die

    Reply
  • Ashley

    How come this product is on sale on eBay and Amazon? It’s still under trial?

    Reply
    • LFCT

      Scientists have isolated a chemical from the berry of a Australian plant endemic only to one region of Australia and have demonstrated promising early results regarding the compound’s ability to destroy tumors in mice, cats, dogs, and horses through direct injections; clinical trials are currently underway for its use in animals and humans.
      Cancer is an extremely broad class of diseases for which no single drug is likely ever to be a “cure”; in this case, a specific chemical found in the Australian berry, isolated in a lab, have been shown to destroy some types of tumors in a variety of animals and laboratory settings; the berry itself would be of little medical value, and the chemical’s efficacy in treating tumors on humans has yet to be established.
      Our Thoughts? This is not THE cure but it may be part of an effective treatment.

      Reply
  • Seth Tyrssen

    Such things “never make it onto the market” because they WORK. We’ve had cures for cancer since 1898; snakeroot, cannabis oil, sonic frequencies, and much more. But when they find anything that works, it’s either derided as “quack pseudoscience” or gets tangled up in “testing” forever. With prostate cancer myself, I have a vested interest in studying such things. When I was told what the AMA-approved “treatments” were, I laughed at ’em and said I wasn’t gonna get irradiated or chemically castrated, but I WOULD write ’em a booklet called “How To Cure Cancer” once mine is finally beaten. Most people don’t die from the cancer, they die from their TREATMENTS. Do the homework — and you, too, may find yourself saying THE HELL WITH THE AMA.

    Reply
  • Genelle Hogan

    Brother in law was meant to start trial back in a march 2014. Were organizing directly with Qbiotics. They kept putting it off as CEO was in USA at the time. He was approved for trial head and neck cancer. Died prior to trial starting. Trials still have not started as they were bought out by big Pharma. That is the problem and the hold up. Any new potentially new miracle cancer drug will be a derivative of ebc46. That’s my take anyway.

    Reply
    • LFCT

      So sorry to hear about your brother-in-law, Genelle – our heartfelt condolences to you and the rest of the family.
      Yes, unfortunately you are correct – Big Pharma is holding us hostage – SO not fair!!

      Reply
  • Helen Black

    I am trying to type LOSING, sorry.

    Reply
    • LFCT

      Haha, don’t worry, Helen, I got it 😀
      As far as why they don’t push it through, who knows? It takes years and loads of $$ for all this research and to get it to human-trial stage… Hopefully we will have more treatments soon, especially for Childhood Cancer which has been sorely neglected 🙁

      Reply
  • Helen Black

    I meant looking money from other cancer drugs.

    Reply
  • Helen Black

    This seems very promising yet they have been researching since 2014, why not push it through to save some lives?
    If cancer can be cured so quickly the big money makers will be looking on other drugs and there may not be a big profit margin on this new treatment. No wonder people are cynical and not trusting traditional medicine anymore.

    Reply
  • Sab

    Hi,
    Thanks for this information. I had been searching various sites to find more about this EBC 46 injection.
    I am trying to get more info on how to get in touch with the researchers behind this treatment. And if one wants to put their hand up for becoming the candidate for the trial.

    Reply
    • LFCT

      Hi there, sorry we have no further information. The best may be to google “EBC 46 Clinical Trial” or some such. Good Luck!

      Reply

Leave us a comment so that we can see whether we are delivering relevant information or not, and please share our posts :-D

%d bloggers like this: